Related Experiment Video
Updated: Oct 18, 2025

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
Health care practitioners' experience-based opinions on providing care after a positive newborn screen for Pompe
Laura Davids1, Yuxian Sun2, Reneé H Moore3
1Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, United States of America.
Insights
Genetic health care practitioners largely support Pompe disease (PD) on newborn screening (NBS). However, challenges exist in follow-up care for later-onset PD (LOPD) compared to infantile-onset PD (IOPD).
Area of Science:
- Medical Genetics
- Public Health Screening
- Pediatric Care
Background:
- Newborn screening (NBS) for Pompe disease (PD) is controversial, particularly regarding later-onset forms (LOPD).
- Current NBS technology cannot distinguish infantile-onset PD (IOPD) from LOPD without clinical follow-up.
- Understanding healthcare practitioners' (HCPs) experiences is crucial for evaluating PD inclusion in NBS.
Purpose of the Study:
- To explore genetic HCPs' experiences and challenges in providing NBS patient care for PD in the US.
- To assess HCPs' opinions on the inclusion of PD in NBS programs.
- To identify barriers and facilitators in managing patients identified through NBS for PD.
Main Methods:
- An online survey was distributed to genetic counselors, geneticists, NBS follow-up care coordinators, and nurse practitioners.
- The survey targeted HCPs caring for patients with positive NBS results for PD.
- Analysis included responses from 78 participating HCPs across the US.
Main Results:
- The majority of HCPs support including PD in NBS.
- Most HCPs believe states have adequate resources for IOPD follow-up, but fewer (74.6%) feel this for LOPD.
- Common barriers include delays in results, insurance issues for testing, and family difficulties accessing care, with more barriers reported for LOPD.
Conclusions:
- HCPs perceive significant challenges in managing LOPD identified through NBS, including psychological burden and unnecessary medicalization.
- There is a need for enhanced education for pediatricians and specialists, evidence-based guidelines, and family support resources for LOPD.
- While supporting PD on NBS, concerns about LOPD care necessitate targeted improvements in healthcare infrastructure and family support.
Abstract:
The addition of Pompe disease (PD) and other conditions with later-onset forms to newborn screening (NBS) in the United States (US) has been controversial. NBS technology cannot discern infantile-onset PD (IOPD) from later-onset PD (LOPD) without clinical follow-up. This study explores genetic health care practitioners' (HCPs) experiences and challenges providing NBS patient care throughout the US and their resultant opinions on NBS for PD. An online survey was distributed to genetic counselors, geneticists, NBS follow-up care coordinators, and nurse practitioners caring for patients with positive NBS results for PD. Analysis of 78 surveys revealed the majority of participating HCPs support inclusion of PD on NBS. Almost all HCPs (93.3%) feel their state has sufficient resources to provide follow-up medical care for IOPD; however, only three-fourths (74.6%) believed this for LOPD. Common barriers included time lag between NBS and confirmatory results, insurance difficulties for laboratory testing, and family difficulties in seeking medical care. HCPs more frequently encountered barriers providing care for LOPD than IOPD (53.9% LOPD identified ≥3 barriers, 31.1% IOPD). HCPs also believe creation of a population of presymptomatic individuals with LOPD creates a psychological burden on the family (87.3% agree/strongly agree), unnecessary medicalization of the child (63.5% agree/strongly agree), and parental hypervigilance (68.3% agree/strongly agree). Opinions were markedly divided on the use of reproductive benefit as a justification for NBS. Participants believe additional education for pediatricians and other specialists would be beneficial in providing care for patients with both IOPD and LOPD, in addition to the creation of evidence-based official guidelines for care and supportive resources for families with LOPD.
More Related Videos
19:15Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Methods of Documentation II: POMR
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
PPE Use in Healthcare Settings I: Donning
Methods of Documentation III: PIE
Cardiomyopathy V: Interprofessional Care
Patient-centered Care